NMPA-2021-0004-V004

Type IA variation for application NMPA-2021-0004. Type IA variation: Formulation Change for Neprilozone — major revision

Variation Number
NMPA-2021-0004-V004
Type
Type IA
Application
NMPA-2021-0004
Change
CHG-2021-0004
Status
Active
Fee
€2,338
Submitted
—
Approved
—
Description

Type IA variation: Formulation Change for Neprilozone — major revision